David H. Epstein

MedicineNeurosciencePsychologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 40 papers. Top paper: “When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use”.

When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use

The American Journal of Drug and Alcohol Abuse(2021)10.1080/00952990.2021.1904408

N/A

0.581DataRank · unranked

47 citations

Jeffrey M. Rogers, Justin C. Strickland, David H. Epstein, Kirsten E. Smith

Health Outcomes by Neighborhood (HON): Effects of Neighborhood, Social Instability, and Health Factors on 12-Month Trajectories of Substance-Use Disorder Symptoms

Substance Use & Misuse(2023)10.1080/10826084.2023.2223258

N/A

0.112DataRank · unranked

1 citations

Leigh V. Panlilio, Sara K. Hertzel, Jeremiah W. Bertz, Matthew Tyburski, John R. Etter +4 more

Objective Neighborhood-Level Disorder Versus Subjective Safety as Predictors of HIV Transmission Risk and Momentary Well-Being

AIDS and Behavior(2024)10.1007/s10461-024-04413-z

N/A

0.104DataRank · unranked

1 citations

Kenzie L. Preston, Jeremiah W. Bertz, Landhing M. Moran, Matthew Tyburski, Sara K. Hertzel +5 more

Bots and Misinformation Spread on Social Media: Implications for COVID-19

Journal of Medical Internet Research(2021)10.2196/26933

N/A

0DataRank · unranked

223 citations

Salvatore Giorgi, Amanda Devoto, Muhammad Mahbubur Rahman, Lyle Ungar, H. Andrew Schwartz +4 more

Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced study.

Experimental and Clinical Psychopharmacology(2021)10.1037/pha0000518

N/A

0DataRank · unranked

49 citations

Kelly E. Dunn, Oliver Grundmann, Albert Garcia‐Romeu, Jeffrey M. Rogers, Marc T. Swogger +2 more

Potential Value of the Insights and Lived Experiences of Addiction Researchers With Addiction

Journal of Addiction Medicine(2021)10.1097/adm.0000000000000867

N/A

0DataRank · unranked

31 citations

Kirsten E. Smith, Noel Vest, Devin P. Effinger, David H. Epstein, Samuel W. Stull

Kratom Use in the US: Both a Regional Phenomenon and a White Middle-Class Phenomenon? Evidence From NSDUH 2019 and an Online Convenience Sample

Frontiers in Pharmacology(2021)10.3389/fphar.2021.789075

N/A

0DataRank · unranked

30 citations

Kirsten E. Smith, Justin C. Strickland, David H. Epstein, Jeffrey M. Rogers

Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use

Psychopharmacology(2021)10.1007/s00213-021-05782-2

N/A

0DataRank · unranked

27 citations

Samuel W. Stull, Jeremiah W. Bertz, Albert J. Burgess-Hull, Stephanie T. Lanza, Brenda Curtis +4 more

Anhedonia and Substance Use Disorders by Type, Severity, and With Mental Health Disorders

Journal of Addiction Medicine(2021)10.1097/adm.0000000000000891

N/A

0DataRank · unranked

20 citations

Jeremiah W. Bertz, David H. Epstein, Bethany C. Bray, Stephanie T. Lanza, Samuel W. Stull

I feel good? Anhedonia might not mean “without pleasure” for people treated for opioid use disorder.

Journal of Abnormal Psychology(2021)10.1037/abn0000674

N/A

0DataRank · unranked

13 citations

Jeremiah W. Bertz, Leigh V. Panlilio, William J. Kowalczyk, Karran A. Phillips, Landhing M. Moran +6 more

Longitudinal patterns of momentary stress during outpatient opioid agonist treatment: A growth-mixture-model approach to classifying patients

Drug and Alcohol Dependence(2021)10.1016/j.drugalcdep.2021.108884

N/A

0DataRank · unranked

12 citations

Kirsten E. Smith, Destiny Schriefer, Leigh V. Panlilio, David H. Epstein, Kenzie L. Preston +1 more

Quality of life during a randomized trial of a therapeutic-workplace intervention for opioid use disorder: Web-based mobile assessments reveal effects of drug abstinence and access to paid work

Drug and Alcohol Dependence Reports(2021)10.1016/j.dadr.2021.100011

N/A

0DataRank · unranked

4 citations

Kirsten E. Smith, Leigh V. Panlilio, Samuel W. Stull, David Reamer, Marie-Louise Murville +7 more

Bots and Misinformation Spread on Social Media: Implications for COVID-19 (Preprint)

(2021)10.2196/preprints.26933

N/A

0DataRank · unranked

9 citations

Salvatore Giorgi, Amanda Devoto, Muhammad Mahbubur Rahman, Lyle Ungar, H. Andrew Schwartz +4 more

Kratom use as more than a “self-treatment”

The American Journal of Drug and Alcohol Abuse(2022)10.1080/00952990.2022.2083967

N/A

0DataRank · unranked

60 citations

Kelly E. Dunn, Jeffrey M. Rogers, Oliver Grundmann, Christopher R. McCurdy, Albert Garcia‐Romeu +4 more

Assessment of Kratom Use Disorder and Withdrawal Among an Online Convenience Sample of US Adults

Journal of Addiction Medicine(2022)10.1097/adm.0000000000000986

N/A

0DataRank · unranked

39 citations

Kelly E. Dunn, Jeffrey M. Rogers, Albert Garcia‐Romeu, Justin C. Strickland, David H. Epstein +1 more

Trajectories of craving during medication-assisted treatment for opioid-use disorder: Subtyping for early identification of higher risk

Drug and Alcohol Dependence(2022)10.1016/j.drugalcdep.2022.109362

N/A

0DataRank · unranked

21 citations

Leigh V. Panlilio, Kenzie L. Preston, David H. Epstein, Albert J. Burgess-Hull

Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder

Neuropsychopharmacology(2022)10.1038/s41386-022-01352-y

N/A

0DataRank · unranked

16 citations

Chung Jung Mun, David H. Epstein, Karran A. Phillips, Patrick H. Finan, Kenzie L. Preston +1 more

Being at work improves stress, craving, and mood for people with opioid use disorder: Ecological momentary assessment during a randomized trial of experimental employment in a contingency-management-based therapeutic workplace

Behaviour Research and Therapy(2022)10.1016/j.brat.2022.104071

N/A

0DataRank · unranked

18 citations

Leigh V. Panlilio, Samuel W. Stull, Kirsten E. Smith, David Reamer, August F. Holtyn +7 more

Nonfatal opioid overdoses before and after Covid-19: Regional variation in rates of change

PLoS ONE(2022)10.1371/journal.pone.0263893

N/A

0DataRank · unranked

13 citations

Kirsten E. Smith, Leigh V. Panlilio, Destiny Schriefer, Kenzie L. Preston, Aliese Alter +7 more

Variability in intensively assessed mood: Systematic sources and factor structure in outpatients with opioid use disorder.

Psychological Assessment(2022)10.1037/pas0001160

N/A

0DataRank · unranked

7 citations

Jacqueline Mogle, Jeremiah W. Bertz, Albert J. Burgess-Hull, Leigh V. Panlilio, Stephanie T. Lanza +3 more

Were self-described introverts "immune" to increased drug use and entrapment during the pandemic?

Drug and Alcohol Dependence Reports(2022)10.1016/j.dadr.2022.100024

N/A

0DataRank · unranked

2 citations

Anysia Lee, Kirsten E. Smith, David H. Epstein, Leigh V. Panlilio

Examining the paradoxical effects of kratom: a narrative inquiry

Frontiers in Pharmacology(2023)10.3389/fphar.2023.1174139

N/A

0DataRank · unranked

32 citations

Jeffrey D. Feldman, Kelly E. Dunn, Christopher R. McCurdy, Stephanie T. Weiss, Oliver Grundmann +4 more

Novel methods for the remote investigation of emerging substances: Application to kratom.

Experimental and Clinical Psychopharmacology(2023)10.1037/pha0000656

N/A

0DataRank · unranked

13 citations

Jeffrey D. Feldman, Kelly E. Dunn, Christopher R. McCurdy, Oliver Grundmann, Albert Garcia‐Romeu +7 more

Activity space during treatment with medication for opioid use disorder: Relationships with personality, mood, and drug use

Journal of Substance Use and Addiction Treatment(2023)10.1016/j.josat.2023.209219

N/A

0DataRank · unranked

1 citations

Albert J. Burgess-Hull, Jeffrey D. Feldman, Jeffrey M. Rogers, Matthew Tyburski, Kirsten E. Smith +2 more

The Opioid Overdose Resuscitation Education for Addiction Counselors and Trainees (Opioid Overdose REACT) naloxone response education pilot project improved confidence and knowledge among addiction counselors and trainees

Clinical Toxicology(2023)10.1080/15563650.2023.2229508

N/A

0DataRank · unranked

3 citations

Joni K. Evans, Yasmin Gay, David H. Epstein, Stephanie T. Weiss, Michael S. Argenyi

Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2024.111329

N/A

0DataRank · unranked

27 citations

Stephanie T. Weiss, David H. Epstein, Oliver Grundmann, Katherine Hill, Kirsten E. Smith +1 more

Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder

Current Psychiatry Reports(2024)10.1007/s11920-024-01524-1

N/A

0DataRank · unranked

17 citations

David H. Epstein, Stephanie T. Weiss, Kirsten E. Smith

Kratom (Mitragyna speciosa) use for self-management of pain: Insights from cross-sectional and ecological momentary assessment data

Journal of Pain(2024)10.1016/j.jpain.2024.104726

N/A

0DataRank · unranked

13 citations

Leigh V. Panlilio, Kelly E. Dunn, Johannes Thrul, Christopher R. McCurdy, David H. Epstein +2 more

Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study

Journal of Addiction Medicine(2024)10.1097/adm.0000000000001259

N/A

0DataRank · unranked

24 citations

Jeffrey M. Rogers, Abhisheak Sharma, Christopher R. McCurdy, Stephanie T. Weiss, Kelly E. Dunn +7 more

Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1412397

N/A

0DataRank · unranked

16 citations

Kayla J. Colvin, David H. Epstein, Oliver Grundmann, Christopher R. McCurdy, Kirsten E. Smith +1 more

Time course of kratom effects via ecological momentary assessment, by product type, dose amount, and assayed alkaloid content

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2024.112460

N/A

0DataRank · unranked

10 citations

Leigh V. Panlilio, Abhisheak Sharma, Christopher R. McCurdy, Jeffrey D. Feldman, Sushobhan Mukhopadhyay +5 more

At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use

The American Journal of Drug and Alcohol Abuse(2025)10.1080/00952990.2024.2414319

N/A

0DataRank · unranked

14 citations

Jeffrey M. Rogers, Oliver Grundmann, David H. Epstein, Kirsten E. Smith, Katherine Hill

Chemical Analysis and Alkaloid Intake for Kratom Products Available in the United States

Drug Testing and Analysis(2025)10.1002/dta.3906

N/A

0DataRank · unranked

20 citations

Kirsten E. Smith, Michelle A. Kuntz, Erin C. Berthold, Omar I. Elashkar, Nicholas Guadagnoli +6 more

Looking beyond traditional pain outcomes to better evaluate cannabis’s true potential and limitations in chronic pain management.

Experimental and Clinical Psychopharmacology(2025)10.1037/pha0000795

N/A

0DataRank · unranked

1 citations

Johannes Thrul, David H. Epstein, Chung Jung Mun

Latent Classes of Adverse Childhood Experiences (ACEs) and Adult Substance-use Problems and Psychosocial Outcomes: Complex and Heterogeneous Associations

International Journal of Mental Health and Addiction(2025)10.1007/s11469-025-01527-w

N/A

0DataRank · unranked

1 citations

Rachel Wolchok, Jeffrey M. Rogers, Sophia Selenou-Yemgang, Bianca D. Beckwith, Kirsten E. Smith +2 more

Is bedtime use of kratom (Mitragyna speciosa) a sleep aid or disruptor? Examining its daily effects and individual differences.

Experimental and Clinical Psychopharmacology(2025)10.1037/pha0000794

N/A

0DataRank · unranked

0 citations

Patricia Timmons, Leigh V. Panlilio, Christopher D. Verrico, Ynhi T. Thomas, C. Austin Zamarripa +3 more

Prediction of stress and drug craving ninety minutes in the future with passively collected GPS data

npj Digital Medicine(2020)10.1038/s41746-020-0234-6

N/A

0DataRank · unranked

68 citations

Matthew Tyburski, William J. Kowalczyk, Albert J. Burgess-Hull, Karran A. Phillips, Brenda Curtis +2 more

Impaired olfactory function in substance use disorder

Psychopharmacology(2025)10.1007/s00213-025-06987-5

N/A

0DataRank · unranked

0 citations

Garrick Sherman, David H. Epstein, Thorsten Kahnt, Clara U. Raithel

In a Rat Model of Opioid Maintenance, the G Protein–Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia

Biological Psychiatry(2020)10.1016/j.biopsych.2020.02.014

N/A

0DataRank · unranked

47 citations

Eugene A. Kiyatkin, Hannah Korah, Jennifer K. Hoots, Anum Afzal, David Perekopskiy +7 more

Beyond abstinence and relapse: cluster analysis of drug-use patterns during treatment as an outcome measure for clinical trials

Psychopharmacology(2020)10.1007/s00213-020-05618-5

N/A

0DataRank · unranked

30 citations

Samuel W. Stull, Jeremiah W. Bertz, Albert J. Burgess-Hull, William J. Kowalczyk, Karran A. Phillips +3 more